Company intelligence
Tris Pharma
Passion. Drive. Innovation.
About Tris Pharma
Tris Pharma, Inc. is a leading privately-owned biopharmaceutical company in the U.S. Our focus is on the development and commercialization of innovative medicines that address unmet patient needs and we have more than 150 U.S. and International patents including applications. We market several branded and generic products in the U.S; license our products in the U.S. and international markets and we have a robust pipeline of innovative products, that employ our proprietary science and technology, to meet patients’ needs in neuroscience and other therapeutic categories. Our science and technology make us unique, but it is our team members that set us apart; they are the engine that fuels Tris’ passion and innovation. The Tris team comprises of approximately 500 diverse individuals; one third of whom operate in the field throughout the U.S. while the other two-thirds work from Tris’ NJ operations. Tris colleagues understand the criticality of operating a successful business and take pride in the company’s success. But of equal importance to each member of the team is how we interact with one another on a daily basis. We believe in each other and we believe in respectful, open and honest communications to help support individual and team success. At Tris, we strive to ensure our field and home office teams are connected and engaged. We listen to our teams in numerous ways, including through our Diversity & Inclusion Committee and our Women’s Business Council, to help ensure every employee’s voice is heard. After all, it is our daily interactions with one another that build and sustain our culture, which fuels our growth.
Verified activity
Signals from Tris Pharma
3 published signals
Presence & Recognition
Tris Pharma is hosting the Adneuris team heading to PAINWeek2026 in Las Vegas at booth #313
Reported by Tris Pharma
Presence & Recognition
Tris Pharma participated in a discussion with Dr. Mohammad Ali of Xtalks regarding the current state of pain medicine and new pain drug development.
Reported by James Hackworth
Presence & Recognition
Tris Pharma teams will attend the Hub and Specialty Pharmacy Models West Conference, US Psych Congress 2026, AAP Experience, NEI Fall Congress, and the International Conference on ADHD from September through early December.
Reported by Tris Pharma